Overview
Arteriohepatic dysplasia, also known as Alagille's syndrome, is an autosomal dominant disorder characterized by intrahepatic bile duct paucity leading to cholestasis, along with multisystem involvement including cardiovascular, skeletal, ocular, and facial abnormalities. 135Diagnosis
Clinical Features: Neonatal jaundice, characteristic facies, skeletal anomalies, ocular findings (posterior embryotoxon, Axenfeld's anomaly, pigmentary retinopathy), and cardiovascular issues (pulmonary artery stenosis). 145
Ocular Examination: Early recognition of ocular changes like Axenfeld's anomaly and pigmentary retinopathy aids in diagnosis. 14
Imaging and Tests: Ultrasound for liver and heart abnormalities, ERCP or MRCP for biliary anatomy, and ophthalmologic evaluation for specific ocular features. 13
Genetic Testing: Considered for confirming diagnosis, especially in atypical cases or when family history is unclear. 3Management
Vitamin Supplementation: Early initiation of fat-soluble vitamins (A and E) to address secondary deficiencies. 1
Symptomatic Treatment: Management of cholestasis with ursodeoxycholic acid (dose specifics not provided in abstracts). 5
Cardiovascular Support: Addressing pulmonary artery stenosis with medical or surgical interventions as needed. 6
Liver Function Monitoring: Regular follow-up to monitor liver function and adjust management accordingly. 5
Multidisciplinary Care: Collaboration between hepatologists, cardiologists, ophthalmologists, and orthopedic specialists. 5Special Populations
Pediatrics: Early recognition of ocular and skeletal abnormalities aids in timely diagnosis and management. 14
Comorbidities: Renal disease and hearing loss noted in some families; regular monitoring recommended. 3Key Recommendations
Early Ocular Examination: Essential for distinguishing Alagille's syndrome from other cholestatic conditions and guiding appropriate management. (Evidence: Moderate 14)
Initiate Vitamin A and E Supplementation: To prevent secondary deficiencies due to fat malabsorption. (Evidence: Weak 1)
Multidisciplinary Approach: Necessary for comprehensive care addressing multiple organ systems involved. (Evidence: Expert opinion 5)References
1 Johnson BL. Ocular pathologic features of arteriohepatic dysplasia (Alagille's syndrome). American journal of ophthalmology 1990. link77873-0)
2 Witzleben CL, Finegold M, Piccoli DA, Treem WR. Bile canalicular morphometry in arteriohepatic dysplasia. Hepatology (Baltimore, Md.) 1987. link
3 LaBrecque DR, Mitros FA, Nathan RJ, Romanchuk KG, Judisch GF, El-Khoury GH. Four generations of arteriohepatic dysplasia. Hepatology (Baltimore, Md.) 1982. link
4 Romanchuk KG, Judisch GF, LaBrecque DR. Ocular findings in arteriohepatic dysplasia (Alagille's syndrome). Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 1981. link
5 Riely CA, Cotlier E, Jensen PS, Klatskin G. Arteriohepatic dysplasia: a benign syndrome of intrahepatic cholestasis with multiple organ involvement. Annals of internal medicine 1979. link
6 Watson GH, Miller V. Arteriohepatic dysplasia: familial pulmonary arterial stenosis with neonatal liver disease. Archives of disease in childhood 1973. link